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Abstract
Asthma is an inflammatory condition characterized by the involve-
ment of several mediators, including reactive oxygen species. The aim
of the present study was to investigate the superoxide release and
cellular glutathione peroxidase (cGPx) activity in peripheral blood
granulocytes and monocytes from children and adolescents with
atopic asthma. Forty-four patients were selected and classified as
having intermittent or persistent asthma (mild, moderate or severe).
The spontaneous or phorbol myristate acetate (PMA, 30 nM)-induced
superoxide release by granulocytes and monocytes was determined at
0, 5, 15, and 25 min. cGPx activity was assayed spectrophotometri-
cally. The spontaneous superoxide release by granulocytes from pa-
tients with mild (N = 15), moderate (N = 12) or severe (N = 6) asthma
was higher at 25 min compared to healthy individuals (N = 28, P <
0.05, Duncan test). The PMA-induced superoxide release by granulo-
cytes from patients with moderate (N = 12) or severe (N = 6) asthma
was higher at 15 and 25 min compared to healthy individuals (N = 28,
P < 0.05 in both times of incubation, Duncan test). The spontaneous or
PMA-induced superoxide release by monocytes from asthmatic pa-
tients was similar to healthy individuals (P > 0.05 in all times of
incubation, Duncan test). cGPx activity of granulocytes and mono-
cytes from patients with persistent asthma (N = 20) was also similar to
healthy individuals (N = 10, P > 0.05, Kruskal-Wallis test). We
conclude that, under specific circumstances, granulocytes from chil-
dren with persistent asthma present a higher respiratory burst activity
compared to healthy individuals. These findings indicate a risk of
oxidative stress, phagocyte auto-oxidation, and the subsequent release
of intracellular toxic oxidants and enzymes, leading to additional
inflammation and lung damage in asthmatic children.
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Introduction
The major characteristics of asthma are
reversible airflow obstruction, bronchial hy-
perresponsiveness, and airway inflammation
(1). This is a complex inflammatory disease
that involves leukocytes, airway epithelial
and smooth muscle cells, and several inflam-
matory mediators with multiple effects. The
airway remains edematous and infiltrated
with inflammatory cells, which are predomi-
nantly eosinophils and lymphocytes. Mast
cells play a key role in asthma symptoms,
whereas eosinophils, macrophages and T-
helper 2 cells are involved in the chronic
inflammation that underlies airway hyperre-
sponsiveness (2). Resident or infiltrating in-
flammatory phagocytes in the airways re-
lease reactive oxygen species and other me-
diators with pleiotropic effects (1).
The role of phagocytes in the pathophysi-
ology of asthma is not completely under-
stood. They release enzymes, including ex-
tracellular matrix-degrading proteases, elas-
tase, cytokines, and reactive oxygen species,
which have been implicated in lung injury
(3). The reported effects of reactive oxygen
species in asthma include a decrease of beta-
adrenergic function in lungs, airway smooth
muscle contraction, increased vascular per-
meability, bronchial hyperresponsiveness,
increased mucus secretion, impaired ciliary
activity, generation of chemotactic factors,
lipid peroxidation, and secondary produc-
tion of mediators with a bronchoconstrictor
effect (4,5). Airway inflammation is also
associated with increased activity of the in-
ducible nitric oxide synthase found in respi-
ratory epithelium and activated macrophages
(6). Superoxide and nitric oxide may rapidly
combine to form peroxynitrite, a potent oxi-
dant, leading to the depletion of antioxi-
dants. For instance, the antioxidant glutathi-
one (GSH), which is 100-fold more concen-
trated in the airway epithelial lining fluid
compared with plasma, may be converted to
its oxidized form (GSSG) (7). Thus, subse-
quent lung injury and more inflammation
may take place.
Glutathione peroxidases (GPx) play an
important role in the detoxification of vari-
ous hydroperoxides. Four types of GPx have
been identified: cellular GPx (cGPx), gas-
trointestinal GPx, extracellular GPx, and
phospholipid hydroperoxide GPx (8,9). cGPx
(EC 1.11.1.9), also termed GPX1, is ubiqui-
tously distributed. It reduces hydrogen per-
oxide as well as a wide range of organic
peroxides derived from unsaturated fatty
acids, nucleic acids, and other important
biomolecules (8). At peroxide concentra-
tions encountered under physiological con-
ditions, it is more active than catalase (which
has a higher Km for hydrogen peroxide) and
is also active against organic peroxides. Thus,
cGPx represents a major cellular defense
against toxic oxidant species (9).
The ability of cGPx to reduce peroxides
and hydroperoxides plays a particularly im-
portant role in the anti-oxidant defense sys-
tem of phagocytes, which are subject to auto-
oxidation by their own respiratory burst prod-
ucts (10,11), leading to damage of the sur-
rounding tissues when a great amount of
oxygen radicals are released (12). Thus, oxi-
dative stress is a relevant risk factor for lung
damage in chronic inflammatory diseases
such as asthma (6,13).
The aim of the present study was to in-
vestigate superoxide release and cGPx activ-
ity of granulocytes and monocytes from chil-
dren and adolescents with atopic asthma,
classified according to the Global Initiative
for Asthma (GINA) criteria for evaluation of
disease severity.
Subjects and Methods
Subjects and study design
The study included atopic asthmatic pa-
tients with the following characteristics: 22
males and 22 females, 20 Caucasians and 24
Blacks. The age ranged from 6 to 16 years
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(mean = 10.8 ± 2.85 years, median 11 years).
The height ranged from 115 to 173 cm, and
weight from 21 to 59 kg. Our clinical proto-
col included patients with a combination of
clinical history of recurrent and reversible
symptoms of airway obstruction, high serum
IgE levels, positive skin tests to recognized
allergens, and a family history of allergy
(14). We were not allowed to collect blood
samples from healthy children. Thus, we
selected 28 healthy individuals for the com-
parative group, with an age range of 22-43
years.
The experimental protocol included as-
says of superoxide production and cGPx
activity in peripheral blood granulocytes and
monocytes. Written informed consent was
obtained from all patient’s parents and
healthy individuals prior to the study. The
Medical School Ethics Committee approved
the experimental protocol in accordance to
the Ministry of Health of Brazil (resolution
196/96) and the Helsinki Convention.
Severity of disease was classified ac-
cording to GINA criteria into mild intermit-
tent, mild persistent, moderate persistent,
and severe persistent (15). Patients with
moderate persistent asthma used inhaled
beta2-adrenergic and/or inhaled steroids
(equivalent to 400-800 µg/day budesonide).
Patients with severe persistent asthma used
inhaled beta2-adrenergic and inhaled, but
not systemic steroids (equivalent to 800-
1600 µg/day budesonide).
None of the patients had received non-
steroidal anti-inflammatory drugs, theophyl-
line, leukotriene modifiers, systemic ster-
oids, systemic beta2-adrenergic agents, or
blood transfusion for at least one month
prior to the study. Patients with infections,
airway foreign bodies, or known systemic or
pulmonary chronic diseases such as immu-
nodeficiency, diabetes, ciliary dyskinesia
syndromes, cystic fibrosis, or alpha1-anti-
trypsin deficiency were excluded. Smokers
were excluded from both patient and control
groups.
Isolation of granulocytes and monocytes
Granulocytes and monocytes were iso-
lated by centrifugation of blood samples over
a discontinuous density gradient (Histopaque
1.077 and 1.119 g/ml; Sigma, St. Louis, MO,
USA) followed by adherence of monocytes
to polystyrene plates (16). Contaminating
erythrocytes were removed by hypotonic ly-
sis. Both cell populations were washed three
times in Hank’s balanced salt solution
(HBSS) without phenol red and the final
leukocyte count was adjusted to 2 x 107
cells/ml. Trypan blue exclusion showed
greater than 90% cell viability.
Superoxide anion production
The spontaneous or phorbol myristate
acetate (PMA, 30 nM)-induced superoxide
anion production by leukocytes was assayed
by a spectrophotometric method based on
the superoxide dismutase inhibitable reduc-
tion of cytochrome c, according to McCord
and Fridovich (17), as modified (18). The
absorbance at 550 nm of the supernatants
was monitored at 0, 5, 15, and 25 min. The
amount of superoxide was calculated using
an extinction coefficient of 21,100 M/cm.
The results are reported as nmol of superox-
ide released per 106 cells per sampling time.
This assay was performed in granulocytes
and monocytes from 44 patients and 28
healthy individuals.
Cellular glutathione peroxidase activity
cGPx activity was assayed in peripheral
blood granulocytes and monocytes accord-
ing to the method of Beutler (19), as modi-
fied (20). Leukocytes (106) were incubated
for 5 to 10 min in cuvettes containing 0.05%
Triton X-100, 0.2 nmol GSH, 1 U/ml GSH
reductase and HBSS, pH 7.4. The reaction
was initiated by the addition of t-butyl-hy-
droperoxide. The change in absorbance at
340 nm was monitored at 0 and 1 min.
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Results are reported as nmol of oxidized
NADPH min-1 106 cells-1. This assay was
performed in granulocytes and monocytes
from 20 patients and 10 healthy individuals
according to cell number availability.
Statistical analysis
Comparisons between the patient groups
and healthy individuals were made using the
Duncan or Kruskal-Wallis (21) test as indi-
cated, with the level of significance set at P <
0.05.
Results
The spontaneous superoxide production
by granulocytes from severe, moderate or
mild persistent asthmatic patients was higher
at 25 min of incubation compared to healthy
individuals (Figure 1A, P < 0.05, Duncan
test).
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Figure 1. Superoxide release by
granulocytes and monocytes
from patients with asthma,
grouped according to GINA di-
agnostic criteria. Panel A, Spon-
taneous superoxide (O2-) pro-
duction was measured in granu-
locytes from patients with
asthma grouped according to
GINA criteria and from healthy
individuals at the indicated time
points. The spontaneous super-
oxide production by granulo-
cytes from SP, MOP or MIP
asthmatic patients was higher
at 25 min of incubation, com-
pared to healthy individuals (*P
< 0.05, Duncan test). Panel B,
Phorbol myristate acetate
(PMA)-stimulated O2- production
was measured in granulocytes
from patients with asthma
grouped according to GINA cri-
teria and from healthy individu-
als at the indicated time points.
The PMA-stimulated superoxide
production by granulocytes from
SP and MOP asthmatic patients
was higher compared to healthy
individuals at 15 and 25 min of
incubation (*P < 0.05, Duncan
test). SP = severe persistent (N
= 6), MOP = moderate persist-
ent (N = 12), MIP = mild persist-
ent (N = 15), and MI = mild inter-
mittent asthma (N = 11). Healthy
individuals (N = 28). n
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The PMA-stimulated superoxide produc-
tion by granulocytes from severe and moder-
ate persistent asthmatic patients was higher
compared to healthy individuals at 15 and 25
min of incubation (Figure 1B, P < 0.05,
Duncan test).
However, neither spontaneous nor PMA-
stimulated superoxide production by mono-
cytes from asthmatic patients, grouped ac-
cording to GINA criteria, differed statisti-
cally from healthy individuals (P > 0.05,
Duncan test).
The cGPx activity of granulocytes from
mild persistent (N = 12), moderate persistent
and severe persistent asthmatic children (N
= 8), and healthy individuals (N = 10) were
(mean ± SD, nmol of oxidized NADPH min-1
106 cells-1): 171 ± 75, 181 ± 33, and 197 ± 68,
respectively. The cGPx activity of mono-
cytes from mild persistent (N = 12), moder-
ate persistent and severe persistent asthmatic
children (N = 8), and healthy individuals (N
= 10) were (mean ± standard deviation, nmol
of oxidized NADPH min-1 106 cells-1): 142 ±
52, 151 ± 75, and 136 ± 36, respectively.
Thus, the cGPx activity of granulocytes
or monocytes from children and adolescents
with persistent asthma did not differ from
that of healthy individuals (P > 0.05 in all
situations, Kruskal-Wallis test).
Discussion
Our results show that the spontaneous or
stimulated superoxide production by granu-
locytes from children and adolescents with
persistent asthma is elevated compared to
healthy individuals.
Ethical restrictions were much greater
than ordinary because the study concerned
samples from children. We were not allowed
to obtain bronchoalveolar lavage cells from
our patients with asthma, an apparently more
sensitive approach to the questions we asked.
Thus, we chose to investigate the superoxide
release and cGPx activity of blood leuko-
cytes. Indeed, one must consider that both
bronchoalveolar lavage cells and blood leu-
kocytes are not intralesional lung tissue cells.
In addition, we were also not allowed to
collect blood samples from healthy children.
Thus, we selected 28 healthy individuals for
the comparative group, which could not be
age matched. Previous studies have shown
that the respiratory burst activity of leuko-
cytes from children and adolescents does not
differ significantly from that of adults (22,23).
This similarity allowed us to compare the
NADPH oxidase activity of leukocytes from
children with asthma to measurements in
healthy adult individuals.
Considering the limitation of volume
when collecting blood samples from chil-
dren, we were unable to separate neutrophils
(predominant cells), eosinophils and baso-
phils from the granulocyte pool. Thus, we
chose to perform those tests in granulocytes.
It is generally accepted that eosinophils and
neutrophils produce equivalent amounts of
superoxide, although this is still a controver-
sial issue. Because of differences in the as-
sembly of the NADPH oxidase components,
eosinophils show a trend to release more
extracellular superoxide compared to neu-
trophils (24).
Other studies have demonstrated that leu-
kocytes from asthmatic patients show higher
superoxide production compared to healthy
individuals, particularly during asthma at-
tacks (6,24-31). In the present, more de-
tailed, study, pediatric patients with chronic
asthma were for the first time carefully clas-
sified according to GINA criteria. In addi-
tion, we have assessed both respiratory burst
and cGPx activity in granulocytes and mono-
cytes. Only patients with persistent asthma
showed a significant increase in superoxide
release by granulocytes. These findings dem-
onstrate at least a partial relationship be-
tween asthma severity and respiratory burst
activity in peripheral blood granulocytes from
pediatric patients.
Several studies have demonstrated that
GPx activity in asthmatic patients varies ac-
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cording to cell lineage or body fluid. GPx
activity may be lower in platelets, normal or
lower in red blood cells, lower or increased
in plasma, and normal or lower in whole
blood (6,13,26,32,33). These conflicting data
may be the result of assaying distinct iso-
forms of GPx in different blood components
from heterogeneous asthmatic patients. To
date, we have shown that cGPx activity of
leukocytes from pediatric asthmatic patients,
carefully classified according to GINA crite-
ria, was similar to healthy controls and did
not follow the up-regulation of NADPH oxi-
dase activity in the same cells.
We conclude that under specific circum-
stances granulocytes from children and ado-
lescents with persistent asthma produce more
reactive oxygen species compared to healthy
individuals. These reactive species have the
potential to overwhelm the antioxidant sys-
tem, with resultant oxidative stress and dam-
age of surrounding pulmonary tissue. This
process may be a relevant and still uncon-
trolled risk factor in childhood asthma patho-
physiology. In children with asthma, key
markers of inflammation are present early in
life, highlighting the importance of early
intervention and the appropriate use of drugs
that modulate the NADPH oxidase activity
(34), preventing the irreversible lung remod-
eling that contributes to this chronic disease.
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